Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 16:8:624092.
doi: 10.3389/fpubh.2020.624092. eCollection 2020.

Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States

Affiliations

Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States

Masoom Priyadarshini et al. Front Public Health. .

Erratum in

Abstract

Objectives: To estimate years of potential life lost (YPLL) and present value of future lost productivity (PVFLP) associated with premature mortality due to HPV-attributable cancers, specifically those targeted by nonavalent HPV (9vHPV) vaccination, in the United States (US) before vaccine use. Methods: YPLL was estimated from the reported number of deaths in 2017 due to HPV-related cancers, the proportion attributable to 9vHPV-targeted types, and age- and sex-specific US life expectancy. PVFLP was estimated as the product of YPLL by age- and sex-specific probability of labor force participation, annual wage, value of non-market labor, and fringe benefits markup factor. Results: An estimated 7,085 HPV-attributable cancer deaths occurred in 2017 accounting for 154,954 YPLL, with 5,450 deaths (77%) and 121,226 YPLL (78%) attributable to 9vHPV-targeted types. The estimated PVFLP was $3.3 billion for cancer deaths attributable to 9vHPV-targeted types (86% from women). The highest productivity burden was associated with cervical cancer in women and anal and oropharyngeal cancers in men. Conclusions: HPV-attributable cancer deaths are associated with a substantial economic burden in the US, much of which could be vaccine preventable.

Keywords: cervical cancer; human papillomavirus; mortality; oropharyngeal cancer; productivity loss.

PubMed Disclaimer

Conflict of interest statement

VP, BK, CN, and DC are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, who may own stock and/or hold stock options in Merck & Co., Inc., Kenilworth, NJ, USA. MP, SS, and SC are employees of Pharmerit – an OPEN Health Company, paid consultants to Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Cancer deaths by age and sex in the United States in 2017: HPV-associated cancers. HPV, human papillomavirus.

References

    1. Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, et al. . US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. (2015) 107:djv086. 10.1093/jnci/djv086 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . HPV-Associated Cancer Diagnosis by Age (2019). Available online at: https://www.cdc.gov/cancer/hpv/statistics/age.htm (accessed March 25, 2020).
    1. Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human papillomavirus–attributable cancers — United States, 2012–2016. MMWR Morb Mortal Wkly Rep. (2019) 68:724–8. 10.15585/mmwr.mm6833a3 - DOI - PMC - PubMed
    1. Markowitz LE, Gee J, Chesson H, Stokley S. Ten years of human papillomavirus vaccination in the United States. Acad Pediatr. (2018) 18:S3–S10. 10.1016/j.acap.2017.09.014 - DOI - PMC - PubMed
    1. Williams WW, Lu P, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, et al. . Surveillance of vaccination coverage among adult populations - United States, 2015. Morbidity and mortality weekly report. Surveill Summ. (2017) 66:1–28. 10.15585/mmwr.ss6611a1 - DOI - PMC - PubMed

Publication types